Digital download
Access the files immediately after checkout.

Access the files immediately after checkout.
Edit, adapt and present the analysis in familiar formats.
Map Stars, Cash Cows, Question Marks and Dogs.
Compare where to invest, maintain or rationalize.
Turn portfolio position into clear priorities.
Safran Identity & Security’s BCG Matrix preview shows where its product lines sit in a shifting security market—who’s leading, who’s steady, and who needs a rethink. Want the full picture? Purchase the complete BCG Matrix for quadrant-by-quadrant placements, data-backed recommendations, and a ready-to-use Word report plus an Excel summary to present and act on immediately. Skip the guesswork—get strategic clarity and a practical roadmap to optimize investment and product decisions.
Morpho (now Safran I&S) drives national-scale AFIS/ABIS deployments in 50+ countries, anchoring high-growth biometric programs; law enforcement and civil ID projects expanded in scope and often sit in multiyear contracts exceeding €100m. These programs deliver high share and visibility for Safran I&S but absorbed significant cash for delivery and lifecycle updates. Continued reinvestment turns them into steady revenue generators.
Global air traffic rebounded to near 2019 levels by 2024 (IATA) while over 150 countries issued ePassports (ICAO), driving a surge in automated border control eGates. Morpho’s hardware and matcher accuracy, consolidated into Safran I&S after the 2017 acquisition, gave it a lead as airports scaled rapidly. Large install bases and continual software tuning plus maintenance consume cash in the short term. Stay invested to lock standards and capture follow-on waves.
Accuracy lift from cross-modal fusion met sharp government demand spikes in enrollment and border security, with Morpho algorithms achieving top-tier placements in multiple NIST evaluations that translated into flagship public-sector wins. Growth accelerated but competitive pressure drove longer, costlier sales cycles and proof-of-concepts. Maintain heavy R&D investment: product roadmap and IP are the engine for future recurring revenue.
National eID and civil registry programs sit in Stars: countries moved to digital identity foundations at pace, with over 100 nations advancing national eID projects by 2024; Morpho’s end-to-end enrolment, dedupe and issuance captured top share in active tenders, enabling rapid market leadership.
Programs were complex and capex-heavy early on, often requiring tens-to-hundreds of millions EUR per country; strategy: land the platform now, harvest maintenance and expansions later to monetize long-term recurring revenues.
Law enforcement and border patrols shifted to mobile biometric kits, and Morpho’s portable scanners plus SDKs met that demand curve, driving strong unit growth while imposing recurring hardware refresh and software-support costs. Volume expansion highlighted the need to invest in standardized form factors and platform ecosystems to reduce OPEX and lock in customers. Prioritize capex to cement long-term service revenues.
Safran I&S (Morpho) holds Star positions in national eID, border eGates and law-enforcement biometrics driven by 100+ national eID projects and 50+ AFIS/ABIS deployments (2024); large install bases and top-tier NIST placements support premium pricing and follow-on revenue. Programs require tens–hundreds EURm upfront and heavy short-term cash; reinvestment converts installs into multiyear maintenance and upgrades. Prioritize capex to lock standards and harvest recurring revenues.
| Metric | 2024 |
|---|---|
| National eID reach | 100+ countries |
| AFIS/ABIS deployments | 50+ countries |
| Capex per program | tens–hundreds EURm |
Comprehensive BCG Matrix of Safran I&S products showing Stars, Cash Cows, Question Marks and Dogs with investment, hold, divest guidance.
One-page BCG Matrix placing Safran I&S units in quadrants to simplify portfolio decisions for execs.
The ePassport personalization and issuance business sits in a mature market driven by 5–10 year citizen replacement cycles, yielding predictable volumes and renewals. Morpho (Safran I&S) held entrenched government contracts and deep document‑security know‑how, underpinning sticky revenue streams. Margins remained solid with modest ongoing capex once personalization lines are commissioned, monetized through efficiency gains, SLA renewals, and recurring consumables sales.
LiveScan fingerprint stations sit in the cash cows quadrant: steady demand from police, visa processing and background checks drove recurring service needs in 2024. A high installed base—estimated at over 100,000 units globally in 2024—generates reliable maintenance and parts revenue, while overall market growth was slow and Safran I&S held high share. Optimize service routes and upsell software subscriptions and analytics modules to lift margins.
Enterprise buyers remain locked into proven access-control and time-attendance terminals, favoring Morpho sensors that have led device shortlists across regions. Market growth is low single-digit CAGR, driving predictable orders and steady service revenue streams. Cash-cow dynamics call for maintenance investment, not expansion: keep firmware current and margins protected. Prioritize service upsell and controlled R&D spend.
Cash Cows: Identity proofing modules (dedupe, QA) in Safran I&S exhibit rare switching once embedded in government stacks; public-sector churn <5% in 2024. Upgrades and support yield ~70% gross margins. Market growth modest and recurring (~6% YoY in 2024). Focus on performance tuning and light feature releases to retain seats.
Airports, banks and telcos rely on dependable MRZ/ID readers for passenger processing, KYC and SIM registration; Morpho devices delivered proven units with long lifecycles (typical field life 7–10 years) so the segment behaves as a replacement market rather than a high-growth play in 2024. Focus on tight unit costs and monetize via service bundles and maintenance contracts to sustain margins.
Safran I&S cash cows: ePassport personalization yields steady renewals on 5–10 year replacement cycles; LiveScan had >100,000 units installed in 2024 producing recurring service revenue. Identity proofing shows <5% public‑sector churn and ~70% gross margins (2024). MRZ/ID readers behave as replacement products with 7–10 year field life.
| Segment | 2024 metric | Gross margin | Strategy |
|---|---|---|---|
| ePassport | 5–10y cycles | ~60%* | service & consumables |
| LiveScan | >100,000 units | 55–65% | maintenance upsell |
| Identity proofing | churn <5% | ~70% | performance tuning |
| MRZ readers | 7–10y life | 50–60% | service bundles |
The file you're previewing is the final Safran Identity & Security BCG Matrix you'll receive after purchase. No watermarks or demo content—just a fully formatted, ready-to-use strategic report. It reflects expert analysis tailored for portfolio decisions and competitive positioning. After purchase you’ll get the identical editable file for immediate presentation or planning. No surprises—just deliverable clarity.
Legacy on-prem AFIS modules face aging deployments in saturated regions with limited upsell left by 2024, as competition moved many clients to modern, open platforms. Morphos share eroded where refresh programs failed to land, leaving low growth and shrinking renewal pipelines. Best action is to sunset modules and redeploy support capacity to higher-growth cloud and multimodal biometrics.
In price‑sensitive niches single‑mode iris hardware lost ground as cheaper fingerprint and camera‑based options undercut margins; in 2024 multimodal kits drove the majority of new access‑control deployments. With low share, low growth and little strategic pull‑through inside Safran I&S, heavy turnarounds are unjustified; recommend exit or bundle only with multimodal offerings.
Fraud migrated to account-based and biometric attacks, and buyers in 2024 prioritized biometric-first flows over standalone magstripe/2D verification. The category is now maintenance-only with declining demand as EMV and biometric issuance exceeded over 80% penetration by 2024. Morpho offered minimal differentiation in this segment. Recommend winding down the line to avoid trapping cash and redeploy resources.
Proprietary middleware with limited API openness sits squarely in Dogs: by 2024 developers overwhelmingly favored open, cloud-native stacks, and closed systems stalled integrations and new logos; Safran I&S saw segment share decline and no meaningful growth, so decommission or replace with modern SDKs and open APIs to stop attrition.
By 2024 Safran Identity & Securitys low-end consumer biometrics experiments showed weak brand pull outside core government and enterprise lanes. Retail volumes failed to materialize against commodity vendors, leaving the initiative with low growth and no clear competitive edge. It became a cash sink and was cut to refocus on institutional strengths.
By 2024 these Dogs held <5% portfolio share, averaged -6% YoY growth and generated low margins; recommend sunsetting legacy AFIS modules, exiting single‑mode iris, winding down card/2D fraud lines, and replacing closed middleware with open SDKs while cutting consumer biometrics.
| Product | 2024 Share | Growth | Action |
|---|---|---|---|
| AFIS modules | ≈3% | -8% | Sunset |
| Iris HW | 2‑4% | -5% | Exit/bundle |
| Fraud/2D | ≈4% | -7% | Wind down |
| Closed middleware | ≈3% | -6% | Rebuild open APIs |
Demand trajectory for cloud-native IDaaS inside Safran I&S was strong—global IDaaS market grew an estimated 18–22% YoY in 2024—yet Morpho’s commercial share remains early-stage, mostly project-based. Transitioning from project delivery to SaaS requires upfront R&D and platform CAPEX plus a cultural shift toward recurring-revenue sales. With enterprise and government cloud contract wins, it could become a Star; without decisive commit or strategic partnerships, lingering risks downgrading it to a Dog.
Remote onboarding with liveness and doc‑to‑biometric match sits as a Question Mark for Safran I&S: the global identity verification market was about $15.6B in 2024 with ~13% CAGR, driven by exploding banking and telco KYC demand. Many rivals compete; Morpho owned strong tech but had limited consumer‑channel presence. High growth, low share and high burn for accuracy/UX — go big on GTM or license the core engine.
Edge AI biometrics on mobile cuts inference latency to under 100 ms and can lower cloud-processing costs by up to 60–70% in real deployments, improving UX and recurring spend. The market in 2024 remained nascent and crowded with proprietary OEM stacks across ~1.2 billion annual smartphone shipments, limiting open distribution. Morpho offers competitive algorithms but lacks broad OEM distribution; pursue OEM deals to scale—otherwise returns will remain thin.
Privacy-preserving biometrics (on-device templates) sits in Question Marks: regulatory winds in 2024 — GDPR data-minimization and the EU AI Act treating biometric ID as high-risk — favor minimal data exposure, boosting demand for on-device approaches. Adoption has been early with fluid standards; commercial upside is large if frameworks lock in and interoperability/stability emerge. Safran I&S should fund regulator-aligned pilots and standards work to tip this into star territory.
Air travel is moving toward paperless identity flows, driven by IATA One ID and ICAO/industry DTC pilots with trials at Changi and Schiphol; Morpho (Safran I&S) already supplies eGates and verification but held only small end-to-end share, so growth is real while outcomes and standards remain uncertain. Safran must pick lead airports and alliance partners to scale deployments quickly or exit fast to protect margins.
Question Marks in Safran I&S include cloud-native IDaaS, remote onboarding, edge AI biometrics and on-device privacy biometrics—high market growth (IDaaS +18–22% YoY 2024; IDV ~$15.6B, 13% CAGR) but low share and high upfront CAPEX/R&D. Win requires platform bets, OEM/GTM partnerships and regulator-aligned pilots; failure risks margin erosion and divestment.
| Segment | 2024 market | Growth | Safran share | Action |
|---|---|---|---|---|
| IDaaS/IDV/Edge/On‑device | $15.6B–cloud↑ | 13–22% CAGR | Low | Invest or exit |